Stemtech Medical Devices has developed the Eva Scalp Cooling System, a non-invasive technology that applies precise cooling to the scalp during chemotherapy to reduce blood flow to hair follicles, thereby minimizing hair loss. This system is designed specifically for cancer patients undergoing chemotherapy, enhancing their quality of life by preserving hair during treatment.
Funding
Funding not disclosed
Founders
Product
Problem
Chemotherapy often leads to hair loss, which can significantly impact cancer patients' confidence and quality of life. Existing methods to prevent hair loss during chemotherapy can be invasive or not universally effective.
Solution
Stemtech Medical Devices offers the Eva Scalp Cooling System, a non-invasive solution designed to minimize hair loss during chemotherapy. The system uses advanced scalp cooling technology to precisely control the scalp temperature, reducing blood flow to hair follicles. By limiting the amount of chemotherapy drugs that reach the hair follicles, the Eva Scalp Cooling System helps protect them from damage, resulting in reduced hair loss and healthier hair regrowth after chemotherapy. The system includes the NextGen Duo 2000 and the SmartFit Cool Wrap, offering a comprehensive and patient-friendly approach to scalp cooling.
Target Audience
The primary users are cancer patients undergoing chemotherapy who want to minimize hair loss, as well as hospitals and oncology clinics looking to provide advanced scalp cooling technology.
Features
- Precise cooling mechanism to maintain consistent scalp temperature
- NextGen Duo 2000 system for robust durability and seamless integration with chemotherapy sessions
- SmartFit Cool Wrap adapts to all head sizes for universal comfort
- Non-invasive and patient-friendly design
- Easy-to-use interface for convenient operation
- Integrates seamlessly with chemotherapy sessions for streamlined effectiveness
- Approved by the Indian Regulatory Authority (CDSCO)
- Recommended by International Oncology Guidelines NCCN & ESMO